Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Myriad Genetics (DE:MYD)
FRANKFURT:MYD
Holding DE:MYD?
Track your performance easily
Myriad Genetics (MYD) Ownership Overview
7.66% Insiders
26.53% Mutual Funds
53.02% Other Institutional Investors
12.78% Public Companies and
Individual Investors
The ownership structure of Myriad Genetics (DE:MYD) stock is a mix of institutional, retail and individual investors. Approximately 79.56% of the company’s stock is owned by Institutional Investors, 7.66% is owned by Insiders and 12.78% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Sep 12, 2024 | Dale Muzzey Cso | xxxxxxxxxxxxx | $54957 |
| Sep 09, 2024 | Heiner Dreismann Director | xxxxxxxxxxxxx | $270500 |
| Aug 23, 2024 | Margaret Ancona Svp, Chief Of Staff | xxxxxxxxxxxxx | $320987 |
| May 15, 2024 | Paul Diaz President & Ceo,director | xxxxxxxxxxxxx | $5727291 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Jun 30, 2024 | xxxxxxxxxxxxx | $399994 | |
| Jun 30, 2024 | xxxxxxxxxxxxx | $1467600 | |
| Jun 30, 2024 | xxxxxxxxxxxxx | $1467600 | |
| Jun 30, 2024 | xxxxxxxxxxxxx | $9973516 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 11,226,395 | Institution | 12.36% | 295,130,698 | |
| 9,055,672 | Institution | 9.97% | 238,064,561 | |
| 7,653,907 | Institution | 8.43% | 201,213,561 | |
| 3,938,772 | Institution | 4.34% | 103,546,377 | |
| 3,748,432 | Institution | 4.13% | 98,542,529 | |
| 2,711,018 | Institution | 2.99% | 71,269,952 | |
| 1,597,908 | Institution | 1.76% | 42,007,403 | |
| 1,577,145 | Institution | 1.74% | 41,461,565 | |
| 1,317,113 | Institution | 1.45% | 34,625,584 | |
| 1,035,223 | Institution | 1.14% | 27,214,977 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 7,653,907 | Institution | 8.43% | 201,213,561 | |
| 3,938,772 | Institution | 4.34% | 103,546,377 | |
| 1,597,908 | Institution | 1.76% | 42,007,403 | |
| 1,577,145 | Institution | 1.74% | 41,461,565 | |
| 1,317,113 | Institution | 1.45% | 34,625,584 | |
| 1,035,223 | Institution | 1.14% | 27,214,977 | |
| 899,183 | Institution | 0.99% | 23,638,622 | |
| 683,254 | Institution | 0.75% | 17,962,064 | |
| 502,390 | Institution | 0.55% | 13,207,331 | |
| 446,975 | Institution | 0.49% | 11,750,526 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|
FAQ
Who Owns Myriad Genetics (DE:MYD)?
According to the latest TipRanks data, approximately 53.02% of the company's stock is held by institutional investors, 7.66% is held by insiders, and 12.78% is held by retail investors.
What percentage of Myriad Genetics (DE:MYD) stock is held by institutional investors?
According to the latest TipRanks data, approximately 53.02% of Myriad Genetics (DE:MYD) stock is held by institutional investors.
What percentage of Myriad Genetics (DE:MYD) stock is held by retail investors?
According to the latest TipRanks data, approximately 12.78% of Myriad Genetics (DE:MYD) stock is held by retail investors.
Who owns the most shares of Myriad Genetics (DE:MYD)?
iShares owns the most shares of Myriad Genetics (DE:MYD).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.